Frequently recommended lawyer for pharmaceutical and medical product law
Wolfgang is one of the leading experts on pharmaceutical law and medical device law in Germany. With his many years of industry knowledge and international experience, he represents small and medium-sized companies from the pharmaceutical and medical device industries, as well as global players.
In the Life Sciences team of Taylor Wessing, Wolfgang develops solutions for complex, strategic challenges facing this sector. In addition, he represents his clients' interests before authorities and in court, including in European court proceedings in Luxembourg. Wolfgang is also a lecturer at the University of Münster and at the University of Marburg.
Kommentar zur Verordnung über Medizinprodukte; Co-Author: Dr. Susanne A. Wagner; Beck Verlag; 2023
AMG Kommentar Beck Verlag
MPG Kommentar co-author Beck Verlag
Arzthaftungsprozess, Luchterhand co-author
Arzneimittel und Recht, regular publications
PharmaRecht, regular publications
Medzinprodukte Journal, regular publications
Medizinproduktrecht, regular publications
Frequently recommended lawyer for pharmaceutical and medical product law
Frequently recommended lawyer for healthcare - Hospitals, MVZs and pharmacies
Law firm of the year for IP Law
Recommended Lawyer: Germany - Life Sciences - Transactional
Recommended Lawyer: Germany - Life Sciences - Regulatory
Thought Leader: Germany - Life Sciences
Leading individual: Pharmaceuticals Law
Leading Individual: Health Care Law
Leading individual: Biotechnology Law
Ranked lawyer for Life Sciences
Frequently recommended: pharmaceuticals and medical products
Thought Leaders - Germany - Life Sciences 2023
Leading individual: Health Care Law
Leading individual: Pharmaceuticals Law
Leading individual: Biotechnology Law and Life Sciences Practice
National Leader - Germany - Life Sciences 2023
Ranked with Chambers and Partners for Life Sciences (Germany)
"expert in the field of medical device law, always available, reliable answers and practical solutions", "competent, fast, good network of correspondence lawyers", client
Leading individual: Pharmaceutical law
Leading individual: Biotechnology law
Teva Pharmaceuticals Europe BV on its divestments of portfolios of generic pharmaceutical products (approximately 260 medicinal products) in 24 EU jurisdictions to multiple purchasers, in addition to advising Teva on the divestment of certain parts of its business. The divestments were a condition enforced by the European Commission to approve Teva's USD40.5 billion acquisition of Allergan plc’s global generics and have been run as a competitive auction process, resulting in five asset sales.
A leading international healthcare company on provision of European-wide advice across a variety of legal areas including pharmaceutical law and patents.
par plusieurs auteurs
Chambers Europe 2022 recommends 28 Taylor Wessing lawyers from 21 Practice Areas whilst Data Protection is listed for the first time
par plusieurs auteurs
Taylor Wessing advises Hauck & Aufhäuser and mBank on voluntary public exchange offer of Vita 34 AG to the shareholders of Polish PBKM
Taylor Wessing advises Hauck & Aufhäuser and mBank on voluntary public exchange offer of Vita 34 AG to the shareholders of Polish PBKM
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par Alison Dennis et Alice Matthews
par Colin McCall et Charlie Adams
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs